 IRVINE, Calif., Nov. 13, 2020 GLOBE NEWSWIRE -- Tarsus Pharmaceuticals, Inc. Tarsus NASDAQ: TARS, a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19. 